Lexent Bio
San Francisco, California, United States
About Lexent Bio
Lexent Bio is building novel liquid biopsy technology to change the way we diagnose and treat cancer.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Funding stage: M&A
- Last round: Series Unknown (Jan 2018)
- Website: lexentbio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Wellness
Social Profiles
Canonical: https://fsome.com/organization/lexent-bio-2524706 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.